<DOC>
	<DOC>NCT01163994</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy and safety of 15-day ceftriaxone versus 15-day doxycycline treatment in patients with multiple erythema migrans.</brief_summary>
	<brief_title>Antibiotic Treatment of Multiple Erythema Migrans</brief_title>
	<detailed_description />
	<mesh_term>Erythema</mesh_term>
	<mesh_term>Erythema Chronicum Migrans</mesh_term>
	<mesh_term>Glossitis, Benign Migratory</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>multiple erythema migrans in patients &gt; 15 years a history of Lyme borreliosis in the past pregnancy or lactation immunocompromised status serious adverse event to doxycycline or beta lactam antibiotic taking antibiotic with antiborrelial activity within 10 days</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>erythema migrans</keyword>
	<keyword>Lyme borreliosis</keyword>
	<keyword>ceftriaxone treatment</keyword>
	<keyword>doxycycline treatment</keyword>
	<keyword>outcome</keyword>
	<keyword>subjective symptoms</keyword>
</DOC>